We are live on
!
Find out more
B
Braidwell Portfolio holdings
AUM
$3B
1-Year Est. Return
46.72%
This Fund
S&P 500
This Quarter
Est. Return
+2.32%
1 Year Est. Return
+46.72%
3 Year Est. Return
+56.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.92B
AUM Growth
+$79.1M
(+2.8%)
Cap. Flow
-$811M
Cap. Flow
% of AUM
-27.73%
Top 10 Holdings %
Top 10 Hldgs %
45.84%
Holding
71
New
6
Increased
13
Reduced
17
Closed
13
Top Buys
| 1 |
CAI
Caris Life Sciences
CAI
|
+$197M |
| 2 |
Krystal Biotech
KRYS
|
+$48M |
| 3 |
Edgewise Therapeutics
EWTX
|
+$39.7M |
| 4 |
Inspire Medical Systems
INSP
|
+$31.9M |
| 5 |
Xenon Pharmaceuticals
XENE
|
+$29.2M |
Top Sells
| 1 |
Transmedics
TMDX
|
+$65.9M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
+$38.9M |
| 3 |
iRhythm Holdings
IRTC
|
+$33.1M |
| 4 |
BCAX
Bicara Therapeutics
BCAX
|
+$28.2M |
| 5 |
Kiniksa Pharmaceuticals
KNSA
|
+$21.9M |
Sector Composition
| 1 | Healthcare | 71.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CAI
1
Caris Life Sciences
CAI
$4.94B
| $195M | 6.69% |
+7,316,142
| New | +$197M |
|
2
Neurocrine Biosciences
NBIX
$17.3B
| $146M | 4.99% |
1,160,425
-31,500
| -3% | -$3.61M |
|
|
3
Xenon Pharmaceuticals
XENE
$6.55B
| $113M | 3.86% |
3,605,029
+895,154
| +33% | +$29.2M |
|
4
argenx
ARGX
$54B
| $107M | 3.67% |
194,491
+33,642
| +21% | +$19.5M |
|
|
5
Krystal Biotech
KRYS
$10.3B
| $100M | 3.42% |
727,811
+327,067
| +82% | +$48M |
|
6
Align Technology
ALGN
$13B
| $94M | 3.22% |
496,730
-33,800
| -6% | -$5.97M |
|
7
Legend Biotech
LEGN
$4.46B
| $90.2M | 3.09% |
2,542,104
-435,847
| -15% | -$14.1M |
|
8
Nuvalent
NUVL
$9.81B
| $89.7M | 3.07% |
1,175,876
+334,931
| +40% | +$24.5M |
|
9
CG Oncology
CGON
$6.44B
| $85.4M | 2.92% |
3,283,317
| – | – |
|
|
10
Edgewise Therapeutics
EWTX
$4.39B
| $68.3M | 2.34% |
5,210,831
+2,752,023
| +112% | +$39.7M |
|
|
11
Inspire Medical Systems
INSP
$1.46B
| $67.8M | 2.32% |
522,410
+220,000
| +73% | +$31.9M |
|
12
Apogee Therapeutics
APGE
$10.2B
| $64.2M | 2.2% |
1,478,512
-61,850
| -4% | -$2.35M |
|
13
Glaukos
GKOS
$9.21B
| $62.3M | 2.13% |
603,414
-21,021
| -3% | -$1.97M |
|
14
Danaher
DHR
$142B
| $61.1M | 2.09% |
309,339
| – | – |
|
15
Thermo Fisher Scientific
TMO
$199B
| $54.8M | 1.88% |
135,233
+7,500
| +6% | +$3.14M |
|
16
Intuitive Surgical
ISRG
$138B
| $48.7M | 1.67% |
89,600
+1,600
| +2% | +$837K |
|
|
17
iRhythm Holdings
IRTC
$3.72B
| $46.2M | 1.58% |
300,029
-256,362
| -46% | -$33.1M |
|
18
Adaptive Biotechnologies
ADPT
$916M
| $45M | 1.54% |
3,863,107
-940,687
| -20% | -$8.54M |
|
19
Guardant Health
GH
$21.6B
| $43.6M | 1.49% |
837,800
-489,527
| -37% | -$21.9M |
|
20
Alphatec Holdings
ATEC
$1.39B
| $40.4M | 1.38% |
3,635,172
-624,257
| -15% | -$7.17M |
|
21
Spyre Therapeutics
SYRE
$8.86B
| $38.6M | 1.32% |
2,578,404
| – | – |
|
22
Viking Therapeutics
VKTX
$4.39B
| $38.1M | 1.3% |
1,437,555
+1,600
| +0.1% | +$42.1K |
|
|
23
Transmedics
TMDX
$2.61B
| $34.2M | 1.17% |
255,048
-599,836
| -70% | -$65.9M |
|
24
Penumbra
PEN
$12.5B
| $33.3M | 1.14% |
129,628
+19,500
| +18% | +$5.31M |
|
25
Dyne Therapeutics
DYN
$3.97B
| $31.2M | 1.07% |
3,273,349
-347,995
| -10% | -$3.83M |
|
Similar funds
NC
VVP
SP
DIG
ECP
PCM
ROTUOC
SM